Content about Basal cell carcinoma

July 2, 2012

Increasing one's caffeinated coffee intake could lower one's risk of developing basal cell carcinoma — which is considered the most common form of skin cancer — according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

PHILADELPHIA — Increasing one's caffeinated coffee intake could lower one's risk of developing basal cell carcinoma — which is considered the most common form of skin cancer — according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

January 30, 2012

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating the most common type of skin cancer, the agency said Monday.

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

September 8, 2010

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

ALLEGAN, Mich. The Food and Drug Administration has approved Perrigo's generic drug for treating skin diseases, the drug maker said Wednesday.

 

The FDA approved Perrigo’s imiquimod cream in the 5% strength. The drug is a generic version of Graceway Pharmaceuticals’ Aldara.

 

 

The drug is used to treat actinic keratoses on the face and scalp, superficial basal cell carcinoma and external genital and perianal warts in patients ages 12 years and older.

 

March 7, 2010

The Food and Drug Administration has approved Taro Pharmaceutical Industries’ generic version of a drug...

February 25, 2010

The Food and Drug Administration has given E. Fougera & Co. approval for the first...

January 5, 2010

A new study found that a nonsteroidal anti-inflammatory drug may reduce a patient's risk of...